An Arg Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa tissue factor and catalytic efficiency of factor IXa

被引:9
作者
Hertzberg, MS
Facey, SL
Hogg, PJ
机构
[1] Westmead Hosp, ICPMR, Dept Haematol, Westmead, NSW 2145, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Univ New S Wales, Sch Pathol, Ctr Thrombosis & Vasc Res, Sydney, NSW, Australia
关键词
D O I
10.1182/blood.V94.1.156.413k15_156_163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor IXR94S is a naturally occurring hemophilia B defect, which results from an Arg 94 to Ser mutation in the second epidermal growth factor (EGF)-like module of factor IX, Recombinant factor IXR94S was activated by factor XIa/ calcium with an approximate to 50-fold reduced rate and by factor VIIa/ tissue factor/phospholipid/calcium with an approximate to 20-fold reduced rate compared with wild-type factor IX, The apparent molecular mass of the light chain of factor IXaR94S was approximate to 6 kD higher than that of plasma or wild-type factor IX, which was not corrected by N-glycosidase F digestion. This result indicated the presence of additional O-linked carbohydrate in the mutant light chain, probably at new Ser 94. The initial rate of activation of factor X by factor IXaR94S in the presence of polylysine was 7% +/- 1% of the initial rate of activation of factor X by plasma factor IXa, and the k(c)/K-M for activation of factor X by factor IXaR94S/factor VIIIa/ phospholipid/calcium was 4% +/- 1% of the k(c)/K-m for activation of factor X by plasma factor IXa/factor VIIIa/phospholipid/calcium. The reduced efficiency of activation of factor X by factor IXaR94S in the tenase enzyme complex was due to a 58-fold +/- 12-fold decrease in k(cat) with little effect on K-m. In conclusion, the R94S mutation had introduced an O-linked carbohydrate, which markedly impaired both activation by factor XIa and turnover of factor X in the tenase enzyme complex. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:156 / 163
页数:8
相关论文
共 41 条
[1]   ACTIVATION PEPTIDE OF HUMAN FACTOR-IX HAS OLIGOSACCHARIDES O-GLYCOSIDICALLY LINKED TO THREONINE RESIDUES AT 159 AND 169 [J].
AGARWALA, KL ;
KAWABATA, S ;
TAKAO, T ;
MURATA, H ;
SHIMONISHI, Y ;
NISHIMURA, H ;
IWANAGA, S .
BIOCHEMISTRY, 1994, 33 (17) :5167-5171
[2]  
ASTERMARK J, 1994, J BIOL CHEM, V269, P3682
[3]  
ASTERMARK J, 1992, J BIOL CHEM, V267, P3249
[4]  
ASTERMARK J, 1991, J BIOL CHEM, V266, P2438
[5]  
ATODA H, 1991, J BIOL CHEM, V266, P14903
[6]  
BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820
[7]   GENETIC HETEROGENEITY OF HEMOPHILIA-B [J].
BROWN, PE ;
HOUGIE, C ;
ROBERTS, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (02) :61-&
[8]  
Brozovic M., 1991, PRACTICAL HAEMATOLOG, P279
[9]   MOLECULAR-CLONING OF THE GENE FOR HUMAN ANTI-HEMOPHILIC FACTOR-IX [J].
CHOO, KH ;
GOULD, KG ;
REES, DJG ;
BROWNLEE, GG .
NATURE, 1982, 299 (5879) :178-180
[10]   Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain [J].
Christophe, OD ;
Lenting, PJ ;
Kolkman, JA ;
Brownlee, GG ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :222-227